Research - News
This potential chemotherapeutic agent to treat glioblastoma — a primary brain tumor with dismal survival rates — is a novel small molecule inhibitor.
A UAB physician will co-chair a steering committee of global cystic fibrosis experts and clinical trial investigators to support the design, conduct and execution of the triple combination pivotal study program.
Antarctica’s Larsen C ice shelf has broken away from the mainland, resulting in a one-trillion ton iceberg.
The International Space Station carries a bit of Birmingham on board — high-tech freezers designed and built by the UAB School of Engineering to protect vital scientific experiments. From their mini mission control, staff and students describe the unique challenges of keeping NASA science on ice for more than 90 space missions.
The UAB study could help inform future health care management during early life and the development of interventions aimed at improving quality of life for older individuals.
This novel method improves purification of complex proteins by 10- to 500-fold, and it may aid both research and large-scale industrial production.
UAB research suggests EEG headsets, growing in popularity among consumers, need better security.
This active drug-delivery system addresses the limitations seen for the anti-cancer drug BA-TPQ — poor solubility and low bioavailability.
A new study shows that teens communicating on mobile phones with friends show stronger signs of technology addiction than when communicating with parents.
The new designation will provide training and support to researchers and students, translating ideas to market.
The new study is the first to observe consolation in adult humans. The findings help correct the impression that humans are aggressive by nature and peaceful by culture.
There will be more than 33,000 brain tumors diagnosed in Americans this year, according to the National Cancer Institute; but a UAB neurosurgeon says advances in treatment paint a brighter outlook than in years past.
An oral history of the development of monoclonal antibodies, the foundation of today's most exciting new drug therapies.
The goal is to avoid unnecessary surgery and reduce the number of biopsies of benign nodules and cancers that are unlikely to cause harm.
This is the first demonstration of donor microbes persisting in the recipient following fecal transplant, a finding made possible by a novel method to “fingerprint” individual strains of bacteria.
Birmingham’s culinary scene is making stomachs rumble nationwide, thanks to high praise from Zagat, the James Beard Awards, and just this week, Buzzfeed. Meet some UAB alumni — and a faculty member — cultivating our local flavor, and follow their journeys into the kitchens and restaurants feeding Birmingham’s revitalization.
Michael Birrer, a leading medical oncologist at Harvard University, will take the reins as the new director of the UAB Comprehensive Cancer Center, succeeding the retiring Edward Partridge.
Calvin Kennedy, a nurse at UAB Hospital, is a two-time kidney transplant recipient who has no plans to live an ordinary life.
At a time when medical cannabis and cannabis-based products are gaining traction in the treatment of seizures, one of UAB’s CBD oil investigators serves as a guest editor for a special research journal devoted to cannabinoid research.
Allostery, a fundamental means of regulating enzymes, is crucial for living cells.
Distractions from technology have a detrimental effect on children’s crash risk as pedestrians and drivers.
A biomarker, endothelial mitochondrial function, may be useful for early identification of newborn babies at risk for lung disease and could enable novel therapy approaches.
Funding to UAB for medical research by the National Institutes of Health topped $238 million in 2016, driving innovation and growth.
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
Some of the 18 graduates of the Innovate Birmingham Workforce Program have been offered jobs to begin high-demand information technology careers with local employers like Blue Cross and Blue Shield of Alabama, Brasfield & Gorrie, Regions and UAB.
A UAB symposium on cardiovascular tissue engineering brought together some of the best in the business in this rapidly developing field of translational medicine.
The first target for the UAB spinoff Incysus Ltd. will be glioblastoma. Incysus has just received a European patent for its innovative approach to fighting cancer.
The five-year grant from the NHLBI to the labs of Jennifer and David Pollock also includes a third project at the University of Utah, bringing together three highly successful research entities.
Knowledge from this study and others may help physicians boost healing and prevent heart failure in patients after a heart attack.
A record year for deceased organ donors included more than doubling the number of lungs donated at UAB.